diabetes

DexCom Proudly Sponsors Historic Diabetes Flight Formation Trip to Raise Juvenile Diabetes Research Foundation Funds
Fri, 06/15/12 - 12:57 pm
DexCom
diabetes
research
funding
Novo Nordisk, JDRF collaborating on R&D for type 1 diabetes
Yahoo/Fly on the Wall
Wed, 06/13/12 - 12:38 pm
JDRF Artificial Pancreas Project
type 1 diabetes
Novo Nordisk
diabetes
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
ADA
diabetes
JNJ
Eli Lilly
Novo Nordisk
Sanofi
Bristol-Myers Squibb
ADA cancer-risk data clears Sanofi's Lantus
Fierce Pharma
Tue, 06/12/12 - 10:58 am
diabetes
insulin
Lantus
Sanofi
cancer
Diabetes: J&J's artificial pancreas proves effective in 1st human clinical trials
Tue, 06/12/12 - 12:11 am
Johnson & Johnson
diabetes
clinical trials
Weight loss: EndoBarrier effective against obesity and diabetes | Research Roundup
Tue, 06/12/12 - 12:11 am
weight loss
EndoBarrier
obesity
diabetes
research
Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma
Mon, 06/11/12 - 01:17 pm
Sanofi
Novo Nordisk
ADA
diabetes
Amylin
degludec
Lantus
Victoza
Ampio eye drug meets study goal, shares soar
Reuters
Mon, 06/11/12 - 01:10 pm
Ampio
Optina
retinal swelling
diabetes
Will Johnson & Johnson Strike it Rich With New Drug?
Wall St. Cheat Sheet
Mon, 06/11/12 - 11:24 am
JNJ
canagliflozin
diabetes
Novo's Victoza Leads To Greater Weight Loss Than Byetta
Bloomberg
Mon, 06/11/12 - 10:47 am
Byetta
diabetes
Victoza
Novo Nordisk
Amylin
Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall
Sun, 06/10/12 - 11:16 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
diabetes
Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA
Yahoo/Global NewsWire
Sun, 06/10/12 - 11:14 am
lixisenatide
Zealand Pharma
Sanofi
type 2 diabetes
diabetes
Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
Yahoo/MarketWire
Sun, 06/10/12 - 11:12 am
lixisenatide
type 2 diabetes
diabetes
Sanofi
FYI from Human Genome Sciences: GlaxoSmithKline Announces New Data from Phase 3 Studies of Once-Weekly Albiglutide in Type 2 Diabetes
Yahoo/Business Wire
Sun, 06/10/12 - 11:08 am
albiglutide
type 2 diabetes
diabetes
Human Genome Sciences
GSK
J&J diabetes drug tops older therapies in studies
Reuters
Sat, 06/9/12 - 12:42 pm
JNJ
diabetes
canagliflozin
type 2 diabetes
Januvia
Merck
Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
Yahoo/Business Wire
Sat, 06/9/12 - 12:38 pm
Symlin
type 2 diabetes
diabetes
type 1 diabetes
Amylin
Once-Weekly Bydureon Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:35 pm
type 2 diabetes
diabetes
Bydureon
Amylin
Alkermes
Bydureon Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:33 pm
Bydureon
type 2 diabetes
Amylin
Alkermes
diabetes
Byetta Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:31 pm
Byetta
Amylin
diabetes
type 2 diabetes
Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Yahoo/PR NewsWire
Sat, 06/9/12 - 12:29 pm
LX4211
Lexicon Pharmaceuticals
diabetes
type 2 diabetes

Pages